Search results
Results from the WOW.Com Content Network
Robert Charles Gallo (/ ˈ ɡ ɑː l oʊ /; born March 23, 1937) is an American biomedical researcher.He is best known for his role in establishing the human immunodeficiency virus (HIV) as the infectious agent responsible for acquired immune deficiency syndrome (AIDS) and in the development of the HIV blood test, and he has been a major contributor to subsequent HIV research.
HIV was first identified as the cause of AIDS and isolated in parallel by researchers Luc Montagnier in France and Robert Gallo in the United States in 1983 and 1984. [3] Without treatment, HIV is inevitably fatal, with a median survival time of 8–10 years. [ 4 ]
6000 researchers attended and presented 220 science reports. [1] 900 journalists attended. [1] Vice President George H. W. Bush spoke at the conference on the topic of confidentiality of HIV testing, for which the government was developing a policy. [2] Robert Gallo announced the discovery of HIV-2. [2]
Scientists have successfully zapped HIV out of infected cells — raising hopes of a cure for the chronic disease. The team from Amsterdam UMC used gene-editing technology to eliminate all traces ...
Adam Castillejo, aka the “London patient.”Castillejo, 44, a Venezuelan man living in England, received a stem cell transplant for AML in 2016 and stopped HIV treatment in 2017.
While the World Health Organization reports that an HIV-positive woman on antiretroviral medications can reduce the chance of passing the disease on to her child to below 5%, more than 300,000 ...
[101] [94] It included Robert Gallo, the co-discoverer of HIV, Nobel Prize winners, theologians, hospital administrators, and psychologists. [103] [104] At the opening session of the conference, Cardinal John O'Connor urged the public to be treated with respect and not as public health hazards, as outcasts, or shunned and left to die.
The acronym HIV has been used since 1986 for human immunodeficiency virus, a retrovirus that was first proposed as the cause of AIDS by Luc Montagnier of France, who named it LAV (lymphadenopathy associated virus) and Robert Gallo of the United States, who named it HTLV-III (human T lymphotropic virus type III).